Treatment of superficial ocular infections caused by micro-organisms sensitive to erythromycin. Prophylaxis of ocular inflammation in newborns, caused byNeisseria gonorrhoeae andChlamydia trachomatis.
Composition:
1 g of eye Ointment contains 5 mg of erythromycin.
Action:
Macrolide antibiotic in the form of an ophthalmic preparation. It works on Gram-positive bacteria (a range similar to penicillin) andChlamydia spp., Rikettsia spp., Treponema spp., Actinomyces spp., Mycoplasmaspp., Legionella pneumophila. Erythromycin administered into the conjunctival sac is practically not absorbed into the bloodstream.
Contraindications:
Hypersensitivity to erythromycin or to any of the excipients.
Precautions:
Prolonged use of the ointment can lead to excessive growth of non-susceptible organisms, including fungi. If superinfection occurs, discontinue use and initiate alternative therapy.
Pregnancy and lactation:
There are no data on the topical use of erythromycin in the eye in pregnant women. Erythromycin is excreted in human milk after systemic administration; it is not known whether it is excreted in milk after topical administration to the eye. The possibility of using ointments in pregnant or breast-feeding women should be evaluated by a doctor.
Side effects:
Hypersensitivity reactions may occur.
Dosage:
In superficial eye infections, once a day or more often a small amount of ointment (rice grain size) is added to the conjunctival sac or applying ointment on the outer edges of the eyelids (if there are scabs, they should be first softened with water and removed). In the prevention of ocular inflammation in newborns, the preparation is used once. If the patient uses more than one eye medicine, each of these medicines should be administered with a 5-minute interval; eye ointments should be given last.
(C)
